UPPSALA, SWEDEN / ACCESS Newswire / April 24, 2025 / Senzime (STO
EZI)(OTCQX
NZZF) announces today that the company's annual and sustainability report for 2024 is published and available at the website www.senzime.com "2024 was a year of high growth, successful product launches, publication of favorable clinical studies, and continued commercial expansion.", commented Philip Siberg, CEO of Senzime For further information, please contact: Philip Siberg, CEO of Senzime ABPhone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com Slavoljub Grujicic, CFOPhone: +46 (0) 76 306 60 11, e-mail: slavoljub.grujicic@senzime.com About Senzime Senzime develops CE- and FDA-cleared precision-based patient monitoring solutions to safeguard patients during anesthesia and recovery.
